PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	13.18	15.17	50.18	68.04	85.4	2.2
Short-Term Investments	0.26	0.37	-	-	-	-
Cash & Short-Term Investments	13.44	15.54	50.18	68.04	85.4	2.2
Cash Growth	-58.82%	-69.03%	-26.25%	-20.33%	3778.14%	146.08%
Other Receivables	4.61	3.7	-	-	-	-
Total Trade Receivables	4.61	3.7	-	-	-	-
Other Current Assets	1.06	3.14	0.26	0.11	0.09	0.07
Total Current Assets	19.11	22.38	50.44	68.15	85.49	2.28
Other Intangible Assets	1.55	1.55	1.55	3.55	3.55	3.55
Long-Term Investments	19.64	22.47	2.76	1.57	1.57	1.57
Other Long-Term Assets	4.82	8.77	7.91	0.01	0.01	0.01
Total Assets	45.11	55.17	59.9	73.28	90.62	7.4
Accounts Payable	0.47	0.4	0.39	0.13	0.21	0.17
Accrued Expenses	0.6	2.52	0.74	0.46	0.5	0.55
Other Current Liabilities	-	-	6.3	-	-	-
Total Current Liabilities	1.06	2.91	7.42	0.59	0.7	0.72
Other Long-Term Liabilities	0.46	0.36	12.97	-	-	-
Total Long-Term Liabilities	0.46	0.36	12.97	-	-	-
Total Liabilities	1.52	3.28	20.39	0.59	0.7	0.72
Preferred Stock	-	-	11.87	-	-	-
Common Stock	0	0	0	0	0	0
Treasury Stock	-44.61	-44.61	-42.04	-13.56	-	-
Additional Paid-in Capital	181.55	181.49	185.33	202.23	201.58	114.11
Accumulated Other Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Retained Earnings	-93.33	-84.97	-115.63	-115.96	-111.65	-107.41
Shareholders' Equity	43.59	51.89	27.65	72.69	89.92	6.68
Total Liabilities & Equity	45.11	55.17	59.9	73.28	90.62	7.4
Net Cash (Debt)	13.44	15.54	50.18	68.04	85.4	2.2
Net Cash Growth	-13.50%	-69.03%	-26.25%	-20.33%	3778.14%	168.66%
Net Cash Per Share	1.90	2.12	5.24	3.49	5.50	1.52
Book Value	43.59	51.89	27.65	72.69	89.92	6.68
Book Value Per Share	6.17	7.08	2.89	3.73	5.79	4.61
Tangible Book Value	42.04	50.34	26.1	69.14	86.37	3.13
Tangible Book Value Per Share	5.95	6.87	2.72	3.55	5.56	2.16

Updated Sep 15, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q